eribulin mesylate
- Product NDC
- 60505-6289
- 11-digit product format
- 605056289
- Labeler code
- 60505
- Product ID
- 60505-6289_f468a7c7-87bd-afa0-2a13-b0ec564dd3ac
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- eribulin mesylate
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Apotex Corp.
- Application
- ANDA218047
- Marketing category
- ANDA
- Marketing start
- 2024-05-06
- Substance
- ERIBULIN MESYLATE
- Active strength
- .5 mg/mL
- Pharmacologic classes
- Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| AV9U0660CW | ERIBULIN MESYLATE | 441045-17-6 | ERIBULIN MESYLATE |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 60505-6289-0 | 60505628900 | 1 VIAL, SINGLE-DOSE in 1 CARTON (60505-6289-0) / 2 mL in 1 VIAL, SINGLE-DOSE | 2024-05-06 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| eribulin mesylate | Apotex Corp. | Gland Pharma Limited | 2025-09-18 | HUMAN PRESCRIPTION DRUG LABEL | 2 |